| 10407504 |
Antagonists for abdominal vasopressin V2 receptor and uses thereof |
William G. North |
2019-09-10 |
| 10155810 |
Provasopressin antagonists and uses thereof |
William G. North |
2018-12-18 |
| 7557078 |
Morphogen-induced nerve regeneration and repair |
David C. Rueger, Thangavel Kuberasampath, Hermann Oppermann, Engin Ozkaynak, Charles M. Cohen |
2009-07-07 |
| 7196056 |
Protein-induced morphogenesis of kidney tissue |
Charles M. Cohen, Kuber T. Sampath, Hermann Oppermann, David C. Rueger |
2007-03-27 |
| 7176284 |
Osteogenic proteins |
Hermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger |
2007-02-13 |
| 7060680 |
Morphogen treatments for limiting proliferation of epithelial cells |
Charles M. Cohen, Marc F. Charette, Thangavel Kuberasampath, David C. Rueger, Hermann Oppermann +2 more |
2006-06-13 |
| 7056882 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
Thangavel Kuberasampath, Charles M. Cohen, Herrmann Oppermann, Engin Ozkaynak, David C. Rueger +1 more |
2006-06-06 |
| 6919308 |
Osteogenic devices |
Hermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger |
2005-07-19 |
| 6800603 |
Morphogen-induced neural cell adhesion |
David C. Rueger, Thangavel Kuberasampath, Hermann Oppermann, Charles M. Cohen |
2004-10-05 |
| 6723698 |
Methods and compositions for the treatment of motor neuron injury and neuropathy |
David C. Rueger, Kuber T. Sampath, Hermann Oppermann, Charles M. Cohen |
2004-04-20 |
| 6586388 |
Method of using recombinant osteogenic protein to repair bone or cartilage defects |
Hermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger |
2003-07-01 |
| 6565843 |
Protein-induced tissue morphogenesis |
Charles M. Cohen, Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger |
2003-05-20 |
| 6551995 |
Osteogenic devices |
Hermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger |
2003-04-22 |
| 6531445 |
Protein-induced morphogenesis in liver tissue |
Charles M. Cohen, Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger |
2003-03-11 |
| 6506729 |
Methods and compositions for the treatment and prevention of Parkinson's disease |
David C. Rueger, Kuber T. Sampath, Charles M. Cohen, Hermann Oppermann |
2003-01-14 |
| 6495513 |
Morphogen-enhanced survival and repair of neural cells |
David C. Rueger, Thangavel Kuberasampath, Hermann Oppermann, Engin Ozkaynak, Charles M. Cohen |
2002-12-17 |
| 6399569 |
Morphogen treatments for limiting proliferation of epithelial cells |
Charles M. Cohen, Marc F. Charette, Thangavel Kuberasampath, David C. Rueger, Hermann Oppermann +2 more |
2002-06-04 |
| 6333312 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
Thangavel Kuberasampath, Charles M. Cohen, Herrmann Oppermann, Engin Ozkaynak, David C. Rueger +1 more |
2001-12-25 |
| 6288031 |
Method for reducing extravasation of effector cells |
Thangavel Kuberasampath, Herrmann Oppermann, David C. Rueger, Charles M. Cohen |
2001-09-11 |
| 6211146 |
60A protein-induced morphogenesis |
Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger, Charles M. Cohen |
2001-04-03 |
| 6194376 |
Method for modulating inflammatory response comprising administering morphogen |
Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger, Charles M. Cohen |
2001-02-27 |
| 6153583 |
OP-3 induced morphogenesis |
Hermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger, Charles M. Cohen |
2000-11-28 |
| 6090776 |
Morphogen treatment of organ implants |
Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger, Charles M. Cohen, John E. Smart |
2000-07-18 |
| 6077823 |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
Thangavel Kuberasampath, Hermann Oppermann, David C. Rueger, Charles M. Cohen, John E. Smart |
2000-06-20 |
| 6022853 |
Morphogen-enriched dietary composition |
Thangavel Kuberasampath, Charles M. Cohen, David C. Rueger, Hermann Oppermann |
2000-02-08 |
